These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20844001)

  • 1. Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression.
    Guigon CJ; Kim DW; Zhu X; Zhao L; Cheng SY
    Endocrinology; 2010 Nov; 151(11):5528-36. PubMed ID: 20844001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor.
    Guigon CJ; Zhao L; Lu C; Willingham MC; Cheng SY
    Mol Cell Biol; 2008 Jul; 28(14):4598-608. PubMed ID: 18474620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canonical Thyroid Hormone Receptor β Action Stimulates Hepatocyte Proliferation in Male Mice.
    Hönes GS; Kerp H; Hoppe C; Kowalczyk M; Zwanziger D; Baba HA; Führer D; Moeller LC
    Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35038735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
    Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
    Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone: identification of a thyroid hormone response element in the murine Fgfr1 promoter.
    O'Shea PJ; Guigon CJ; Williams GR; Cheng SY
    Endocrinology; 2007 Dec; 148(12):5966-76. PubMed ID: 17761769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
    Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
    Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
    Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
    Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear corepressors mediate the repression of phospholipase A2 group IIa gene transcription by thyroid hormone.
    Sharma P; Thakran S; Deng X; Elam MB; Park EA
    J Biol Chem; 2013 Jun; 288(23):16321-16333. PubMed ID: 23629656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
    Lee KC; Li J; Cole PA; Wong J; Kraus WL
    Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling.
    O'Shea PJ; Kim DW; Logan JG; Davis S; Walker RL; Meltzer PS; Cheng SY; Williams GR
    J Biol Chem; 2012 May; 287(21):17812-17822. PubMed ID: 22442145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements.
    Sar P; Peter R; Rath B; Das Mohapatra A; Mishra SK
    PLoS One; 2011; 6(6):e20861. PubMed ID: 21687737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
    Park JW; Zhao L; Willingham MC; Cheng SY
    Mol Carcinog; 2017 Feb; 56(2):489-498. PubMed ID: 27254276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation (E333D) in the thyroid hormone beta receptor causing resistance to thyroid hormone syndrome.
    Maraninchi M; Bourcigaux N; Dace A; El-Yazidi C; Malezet-Desmoulins C; Krempf M; Torresani J; Margotat A
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):569-76. PubMed ID: 17177139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific histone lysine 4 methylation patterns define TR-binding capacity and differentiate direct T3 responses.
    Bilesimo P; Jolivet P; Alfama G; Buisine N; Le Mevel S; Havis E; Demeneix BA; Sachs LM
    Mol Endocrinol; 2011 Feb; 25(2):225-37. PubMed ID: 21239616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression.
    Kim WG; Zhu X; Kim DW; Zhang L; Kebebew E; Cheng SY
    Endocrinology; 2013 Jan; 154(1):25-35. PubMed ID: 23183175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The targeted inactivation of TRβ gene in thyroid follicular cells suggests a new mechanism of regulation of thyroid hormone production.
    Selmi-Ruby S; Bouazza L; Obregon MJ; Conscience A; Flamant F; Samarut J; Borson-Chazot F; Rousset B
    Endocrinology; 2014 Feb; 155(2):635-46. PubMed ID: 24265449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G ATA2 mediates the negative regulation of the prepro-thyrotropin-releasing hormone gene by liganded T3 receptor β2 in the rat hypothalamic paraventricular nucleus.
    Kuroda G; Sasaki S; Matsushita A; Ohba K; Sakai Y; Shinkai S; Nakamura HM; Yamagishi S; Sato K; Hirahara N; Oki Y; Ito M; Suzuki T; Suda T
    PLoS One; 2020; 15(11):e0242380. PubMed ID: 33201916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the hepatic LDL receptor promoter by thyroid hormone.
    Lopez D; Abisambra Socarrás JF; Bedi M; Ness GC
    Biochim Biophys Acta; 2007 Sep; 1771(9):1216-25. PubMed ID: 17572141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.
    Kim WG; Zhao L; Kim DW; Willingham MC; Cheng SY
    Thyroid; 2014 Feb; 24(2):260-9. PubMed ID: 23731250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential Role of GATA2 in the Negative Regulation of Type 2 Deiodinase Gene by Liganded Thyroid Hormone Receptor β2 in Thyrotroph.
    Matsunaga H; Sasaki S; Suzuki S; Matsushita A; Nakamura H; Nakamura HM; Hirahara N; Kuroda G; Iwaki H; Ohba K; Morita H; Oki Y; Suda T
    PLoS One; 2015; 10(11):e0142400. PubMed ID: 26571013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.